Search icon

LEXEO THERAPEUTICS, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: LEXEO THERAPEUTICS, INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 04 Aug 2021 (4 years ago)
Entity Number: 6236822
ZIP code: 12207
County: New York
Place of Formation: Delaware
Foreign Legal Name: LEXEO THERAPEUTICS, INC.
Address: 80 STATE STREET, ALBANY, NY, United States, 12207
Principal Address: 345 PARK AVENUE SOUTH, 6TH FLOOR, NEW YORK, NY, United States, 10010

DOS Process Agent

Name Role Address
C/O CORPORATION SERVICE COMPANY DOS Process Agent 80 STATE STREET, ALBANY, NY, United States, 12207

Chief Executive Officer

Name Role Address
R. NOLAN TOWNSEND Chief Executive Officer 345 PARK AVENUE SOUTH, 6TH FLOOR, NEW YORK, NY, United States, 10010

Central Index Key

CIK number:
0001907108
Phone:
(212) 547-9879

Latest Filings

Form type:
424B3
File number:
333-288025
Filing date:
2025-07-01
File:
Form type:
EFFECT
File number:
333-288025
Filing date:
2025-06-30
File:
Form type:
4
Filing date:
2025-06-30
File:
Form type:
4
Filing date:
2025-06-30
File:
Form type:
4
Filing date:
2025-06-30
File:

Commercial and government entity program

CAGE number:
7TL73
Status:
Obsolete
Type:
Non-Manufacturer
CAGE Update Date:
2024-02-29
SAM Expiration:
2022-12-03

Contact Information

POC:
ANASSA MILLER

History

Start date End date Type Value
2022-01-20 2023-08-28 Address 80 STATE STREET, ALBANY, NY, 12207, 2543, USA (Type of address: Service of Process)
2021-08-05 2022-01-20 Address 430 e. 29th st. fl 14, NEW YORK, NY, 10016, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
230828003597 2023-08-28 BIENNIAL STATEMENT 2023-08-01
220120003837 2022-01-20 CERTIFICATE OF CHANGE BY ENTITY 2022-01-20
210805001509 2021-08-04 APPLICATION OF AUTHORITY 2021-08-04

USAspending Awards / Financial Assistance

Date:
2020-07-27
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
CNS GENE THERAPY FOR CLN2 DISEASE USING PARALLEL MULTIPLE ROUTES OF ADMINISTRATION
Obligated Amount:
499916.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2020-06-16
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
GENE THERAPY TO TREAT ETHANOL-INDUCED OSTEOPOROSIS ASSOCIATED WITH ALDEHYDE DEHYDROGENASE 2 DEFICIENCY
Obligated Amount:
252042.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2019-09-23
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
GENE THERAPY TO PROTECT THE LUNG FROM OXIDANT STRESS
Obligated Amount:
224593.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2019-05-23
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
GENE THERAPY TO PREVENT ESOPHAGEAL CANCER ASSOCIATED WITH ALDEHYDE DEHYDROGENASE DEFICIENCY
Obligated Amount:
224970.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2018-02-02
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
OXIDATION-RESISTANT ANTI-PROTEASE THERAPY
Obligated Amount:
1724070.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks Section

Serial Number:
98209821
Mark:
LEXEO THERAPEUTICS
Status:
NOTICE OF ALLOWANCE - ISSUED
Mark Type:
TRADEMARK
Application Filing Date:
2023-10-04
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
LEXEO THERAPEUTICS

Goods And Services

For:
House mark for the following, namely, Pharmaceutical preparations for the treatment of cardiovascular diseases, disorders, and defects; Pharmaceutical preparations for the treatment of Friedreich's Ataxia; Pharmaceutical preparations for the treatment of arrhythmogenic cardiomyopathy; Pharmaceutical...
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
98209814
Mark:
LEXEO
Status:
NOTICE OF ALLOWANCE - ISSUED
Mark Type:
TRADEMARK
Application Filing Date:
2023-10-04
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
LEXEO

Goods And Services

For:
House mark for the following, namely, Pharmaceutical preparations for the treatment of cardiovascular diseases, disorders, and defects; Pharmaceutical preparations for the treatment of Friedreich's Ataxia; Pharmaceutical preparations for the treatment of arrhythmogenic cardiomyopathy; Pharmaceutical...
International Classes:
005 - Primary Class
Class Status:
Active

Court Cases

Court Case Summary

Filing Date:
2023-10-12
Status:
Pending
Nature Of Judgment:
Missing
Jury Demand:
Both plaintiff and defendant demand jury
Nature Of Suit:
Defend Trade Secrets Act

Parties

Party Name:
ROCKET PHARMACEUTICALS, INC.
Party Role:
Plaintiff
Party Name:
LEXEO THERAPEUTICS, INC.
Party Role:
Defendant

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 21 Mar 2025

Sources: New York Secretary of State